» Articles » PMID: 20072631

A Short-duration Dark Adaptation Protocol for Assessment of Age-related Maculopathy

Overview
Publisher Springer
Specialty Ophthalmology
Date 2010 Jan 15
PMID 20072631
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Dark adaptometry may be a useful diagnostic test and clinical trial endpoint for age-related maculopathy (ARM) because impaired night vision is a hallmark of early ARM. A novel dark adaptometer, the AdaptDx, was evaluated for the detection of ARM. The AdaptDx incorporates a 20-minute protocol optimized for the detection of ARM. ARM patients (N = 17) exhibited substantial dark adaptation impairment compared with normal adults (N = 17). The diagnostic sensitivity was 88% and the specificity was 100%. The diagnostic test characteristics of the AdaptDx are similar to previously reported studies using 60- to 120-minute protocols.

Citing Articles

Polygenic risk score impact visual function in healthy: the Northern Ireland Sensory Ageing study.

Tang F, Hogg R, Higgins B, Wright D, Smyth L, Sivaprasad S Eye (Lond). 2025; .

PMID: 39962206 DOI: 10.1038/s41433-025-03642-3.


Choriocapillaris Impairment, Visual Function, and Distance to Fovea in Aging and Age-Related Macular Degeneration: ALSTAR2 Baseline.

Kar D, Amjad M, Corradetti G, Swain T, Clark M, McGwin Jr G Invest Ophthalmol Vis Sci. 2024; 65(8):40.

PMID: 39042400 PMC: 11268449. DOI: 10.1167/iovs.65.8.40.


Repeatability of Rod-Mediated Dark Adaptation Testing in Normal Aging and Early and Intermediate Age-Related Macular Degeneration.

Owsley C, Swain T, McGwin Jr G, Bernard M, Clark M, Curcio C Curr Eye Res. 2024; 49(7):725-730.

PMID: 38439539 PMC: 11199118. DOI: 10.1080/02713683.2024.2326077.


Evaluation of a mobile app for dark adaptation measurement in individuals with age-related macular degeneration.

Pundlik S, Shivshanker P, Nigalye A, Luo G, Husain D Sci Rep. 2023; 13(1):22191.

PMID: 38092820 PMC: 10719237. DOI: 10.1038/s41598-023-48898-5.


Additional measures of macular function beyond visual acuity.

Rios H, Lovestam-Adrian M, Plainis S, Tsilimbaris M, Joussen A, Keegan D Graefes Arch Clin Exp Ophthalmol. 2023; 262(6):1723-1736.

PMID: 37938378 PMC: 11106142. DOI: 10.1007/s00417-023-06272-1.


References
1.
Jackson G, Felix T, Owsley C . The Scotopic Sensitivity Tester-1 and the detection of early age-related macular degeneration. Ophthalmic Physiol Opt. 2006; 26(4):431-7. DOI: 10.1111/j.1475-1313.2006.00390.x. View

2.
Scilley K, Jackson G, Cideciyan A, Maguire M, Jacobson S, Owsley C . Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology. 2002; 109(7):1235-42. DOI: 10.1016/s0161-6420(02)01060-6. View

3.
Davis M, Gangnon R, Lee L, Hubbard L, Klein B, Klein R . The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005; 123(11):1484-98. PMC: 1472813. DOI: 10.1001/archopht.123.11.1484. View

4.
Curcio C, Millican C, Bailey T, Kruth H . Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001; 42(1):265-74. View

5.
Owsley C, McGwin Jr G, Jackson G, Kallies K, Clark M . Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology. 2007; 114(9):1728-35. DOI: 10.1016/j.ophtha.2006.12.023. View